Peptide Stapling: A Novel Approach to Cancer Drug Development
https://reachmd.com/programs/clinicians-roundtable/peptide-stapling-a-novel-approach-to-cancer-drug-development/2429/
Dr. Loren Walensky, Assistant Professor of Pediatric Oncology at Harvard Medical School and Medical Director of the Program of Cancer Chemical Biology at the Dana-Farber Cancer Institute discusses the biology of cell death and how a new chemical technology is yielding a host of new tools to study an
A Life on the Front Lines: The Journey of an Abortion Doctor
https://reachmd.com/programs/clinicians-roundtable/a-life-on-the-front-lines-the-journey-of-an-abortion-doctor/2985/
Enduring death threats and other abuse, carrying a concealed weapon, and wearing a bulletproof vest were as much a part of a normal day for Dr. Susan Wicklund as sipping a cup of coffee or talking on a cell phone. Dr. Michael Greenberg hosts this can’t-miss discussion, no matter your views, explorin
Medical Myths Even Docs Believe
https://reachmd.com/programs/clinicians-roundtable/medical-myths-even-docs-believe/2733/
Turkey gets a bad rap for its tryptophan levels. Ditto cell phones for disrupting sensitive life support instruments. And what about this notion that we only use 10% of our brains? Dr. Aaron Carroll, assistant professor of pediatrics at Indiana University School of Medicine, and author of the articl
https://reachmd.com/programs/washington-health-report/biogeneric-drugs/1801/
Biogenerics are generic versions of biotech drugs made from cells and other living organisms. They could save consumers and the health care system a lot of money. Here to tell us about them is a reporter who has been covering health care for National Journal for more than a decade. She written exten
Dermatology and CTCL: Recommendations
https://reachmd.com/series/dermwire-tv/dermatology-and-ctcl-recommendations/26798/
Larisa J. Geskin, MD, Professor of Dermatology at Columbia University Medical Center, discusses "Time to Act: A Global Patient-Focused Consensus for Improving Care in Cutaneous T-Cell Lymphoma (CTCL)," a global consensus statement from Kyowa Kirin that recommends, among other things, that dermatolog
The Challenges of Diagnosing Diabetes in Children
https://reachmd.com/programs/diabetes-discourse/the-challenges-of-diagnosing-diabetes-in-children/4688/
The incidence of diabetes is increasing per year in the US and globally. The trend data suggests that obesity may be driving autoimmune beta cell failure. Some have questioned whether excess obesity or adiposity might be playing a role in this increased incidence of type 1 diabetes or whether health
https://reachmd.com/programs/focus-on-cancer/genetic-tumor-testing/4365/
A new program at Massachusetts General Hospital in Boston includes extracting the DNA from its cancer patients’ tumors to determine which abnormalities occur in the tumor cells, specific to the type of tumor. From these results, physicians hope to create better, targeted cancer therapies. Host Dr. L
A New Model of Healthcare Delivery
https://reachmd.com/programs/conversations-on-health-care/a-new-model-of-healthcare-delivery/6928/
This week, Mark and Margaret speak with Dr. Joseph C. Kvedar, MD, Founder and Director of the Center for Connected Health. Dr. Kvedar is creating innovative programs to leverage information technology - cell phones, computers, networked devices and simple remote health monitoring tools - to help pro
Do We Need to Temper our Enthusiasm for Incretin-Based Therapy?
https://reachmd.com/programs/diabetes-discourse/do-we-need-to-temper-our-enthusiasm-for-incretin-based-therapy/5947/
There have been impressive results with incretin-based therapy for patients with type 2 diabetes: improved A1C, beta-cell preservation and weight loss are some of the benefits. But do healthcare professionals need to temper their enthusiasm for this novel therapy? Join host Dr. Steven Edelman and hi
Strategies to Overcome Cancer Drug Resistance
https://reachmd.com/programs/focus-on-cancer/strategies-to-overcome-cancer-drug-resistance/3792/
Cancer cells almost always defeat drug therapies. Can combination therapies prevent or overcome drug resistance? Join host Dr. Bruce Bloom as he discusses the research and clinical issues of cancer treatment with Dr. Jeffrey Settleman, professor of medicine at Harvard Medical School and scientific d